{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T23:57:06Z","timestamp":1697414226829},"reference-count":12,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["General Hospital Psychiatry"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1016\/j.genhosppsych.2004.11.006","type":"journal-article","created":{"date-parts":[[2005,3,11]],"date-time":"2005-03-11T18:34:53Z","timestamp":1110566093000},"page":"148-150","source":"Crossref","is-referenced-by-count":3,"title":["Fluvoxamine induced complex partial seizure in the treatment of bulimia nervosa"],"prefix":"10.1016","volume":"27","author":[{"given":"Hitoshi","family":"Nakahira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahito","family":"Tomotake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuro","family":"Ohmori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.genhosppsych.2004.11.006_bib1","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1176\/ajp.140.5.554","article-title":"Bulimia treated with imipramine; a placebo-controlled, double-blind study","volume":"140","author":"Pope","year":"1983","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.genhosppsych.2004.11.006_bib2","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/00004714-198408000-00003","article-title":"A placebo-controlled, double-blind trial of amitriptyline in bulimia","volume":"4","author":"Mitchell","year":"1984","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.genhosppsych.2004.11.006_bib3","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/archpsyc.1992.01820020059008","article-title":"Fluoxetine in the treatment of bulimia nervosa. A multicenter, placebo-controlled, double-blind trial","volume":"49","year":"1992","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.genhosppsych.2004.11.006_bib4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00004714-199602000-00003","article-title":"Fluvoxamine in prevention of relapse in bulimia nervosa: effects on eating-specific psychopathology","volume":"16","author":"Fichter","year":"1996","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.genhosppsych.2004.11.006_bib5","first-page":"289","article-title":"Seizures associated with antidepressants: a review","volume":"54","author":"Rosenstein","year":"1993","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.genhosppsych.2004.11.006_bib6","series-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"1994"},{"key":"10.1016\/j.genhosppsych.2004.11.006_bib7","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000118147","article-title":"Comparison of the (pro)convulsive properties of fluvoxamine and cluvoxamine with eight other antidepressants in an animal model","volume":"12","author":"Krijzer","year":"1984","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.genhosppsych.2004.11.006_bib8","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/0140-6736(90)91938-7","article-title":"Fluvoxamine: an antidepressant with low (or no) epileptogenic effect","volume":"336","author":"Harmant","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.genhosppsych.2004.11.006_bib9","first-page":"296","article-title":"Seizure activity associated with fluoxetine therapy","volume":"8","author":"Weber","year":"1998","journal-title":"Clin. Pharmacol."},{"key":"10.1016\/j.genhosppsych.2004.11.006_bib10","first-page":"628","article-title":"Seizures associated with fluoxetine therapy","volume":"23","author":"Ware","year":"1989","journal-title":"DICP, Ann. Psychopharmacother."},{"key":"10.1016\/j.genhosppsych.2004.11.006_bib11","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1192\/bjp.159.3.433","article-title":"Serotonin reuptake inhibitors, epilepsy and myoclonus","volume":"159","author":"Deahl","year":"1991","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.genhosppsych.2004.11.006_bib12","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1055\/s-2007-979598","article-title":"A seizure, and electroencephalographic signs of a lowered seizure threshold, associated with fluvoxamine treatment of obsessive\u2013compulsive disorder","volume":"28","author":"Trabert","year":"1995","journal-title":"Pharmacopsychiatry"}],"container-title":["General Hospital Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834304001446?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834304001446?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T04:53:36Z","timestamp":1548651216000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163834304001446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["S0163834304001446"],"URL":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2004.11.006","relation":{},"ISSN":["0163-8343"],"issn-type":[{"value":"0163-8343","type":"print"}],"subject":[],"published":{"date-parts":[[2005,3]]}}}